Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe

CompletedOBSERVATIONAL
Enrollment

686

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases
Trial Locations (1)

75008

Carenity, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY